[1] 谢幸,孔北华,段涛.妇产科学[M].9版.北京:人民卫生出版社,2018:204-209.
[2] MASWIME S,BUCHMANN E.A systematic review of maternal near miss and mortality due to postpartum hemorrhage[J].Int J Gynaecol Obstet,2017,137(1):1-7.
[3] KANDEEL M,SANAD Z,ELLAKWA H,et al. Management of postpartum hemorrhage with intrauterine balloon tamponade using a condom catheter in an Egyptian setting[J].Int J Gynecol Obstet,2016,135(3):272-275.
[4] 赵丽琴,郭遂群,林丹.缩宫素引产持续时间与宫缩乏力性产后出血的相关性[J].现代医学,2013, 41(5):332-335.
[5] 金荣,石少权.麦角新碱联合缩宫素治疗临产后剖宫产产后出血的临床观察[J].药物评价研究,2018,41(2):302-304.
[6] 钟柳英,陈敦金,纪艳洁,等.麦角新碱预防高危孕产妇剖宫产出血的疗效观察[J/OL].中华产科急救电子杂志,2018,7(3):180-184.
[7] 张奕晖,顾宁,王志群等.运用十分类系统探索我国计划生育政策改变对剖宫产的影响[J].中华围产医学杂志,2017,20(9):696.
[8] 潘凤英.不同剂量缩宫素用于预防产后出血效果分析[J].白求恩医学杂志,2015,13(1):64-65.
[9] 蔡本硕,杜鹃.某医院前置胎盘患者术中出血相关因素的回顾性分析[J].东南大学学报(医学版),2018,37(5):908-911.
[10] 张力,刘兴会.产后出血的药物治疗评价[J].中国实用妇科与产科杂志,2009,25(2):98-102.
[11] 韩小雪,潘颖,董南,等.静脉滴注新麦角新碱预防产后出血对血压的影响[J/OL].妇产与遗传(电子版),2018,8(1):23-26.
[12] TRIPATHI K D.5-Hydroxytryptamine, its antagonists and drug therapy of migraine[M]//TRIPATHI K D. Essential of medical pharmacology.6th ed.New Delhi:Jaypee brothers,2008:162-172.
[13] BATEMAN B T,HUYBRECHTS K F,HERNANDEZ-DIAZ S,et al.Methylergonovine maleate and the risk of myocardial ischemia and infarction[J].Am J Obstet Gynecol,2013,209(5):459.e1-459.e13. |